|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.031 AUD | 0.00% |
|
+3.33% | +40.91% |
| Apr. 15 | Atomo Diagnostics Wins AU$570,000 HIV Self-Tests Order | MT |
| Mar. 06 | Atomo Diagnostics Wins Order to Supply AU$970,000 Worth of HIV Self-Tests | MT |
Atomo Diagnostics Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was AUD 12.34 million compared to AUD 6.72 million a year ago. Net loss was AUD 5.71 million compared to AUD 6.02 million a year ago.
Basic loss per share from continuing operations was AUD 0.01003 compared to AUD 0.01067 a year ago. Diluted loss per share from continuing operations was AUD 0.01003 compared to AUD 0.01067 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +40.91% | 12.34M | |
| +8.35% | 209B | |
| +9.41% | 175B | |
| +11.75% | 131B | |
| +19.34% | 99.98B | |
| -0.84% | 61.12B | |
| +15.08% | 52.34B | |
| -2.10% | 46.5B | |
| +0.10% | 39.24B | |
| +11.50% | 38.47B |
ATOMO DIAGNOSTICS LIMITED 
